On September 2, 2014, shares in Exelixis, a drug maker that has spent two decades trying to turn the early fruits of genetic research into drugs, plunged 48% as it announced that its cancer drug, Cometriq, did not extend survival in patients with advanced prostate cancer that had spread to [...]
As if male-pattern baldness were not already a curse for self-conscious men everywhere, a Canadian research team is suggesting it could also strongly predict the risk of getting prostate cancer, and more serious cases of the disease.
The University of Toronto scientists even argue the extent of someone’s hair loss might help doctors decide whether to carry out painful biopsies in marginal cases.
LONDON — A man with advanced prostate cancer is believed to have been cured after doctors “shocked” his tumour to death with huge amounts of testosterone.
The result has been described as “unexpected” and “exciting” because most prostate cancer therapies work by depriving tumours of the hormone, which cancer uses as a fuel.
Other men taking part in the trial also showed responses that astounded scientists, with tumours shrinking and the progress of their disease halted.
Bristol-Myers Squibb Co (NYSE:BMY) has announced an exclusive agreement with BAVARIAN NORDIC (OTCMKTS:BVNRY) over the Danish-based company’s prostate cancer drug Prostvac, which is currently undergoing clinical trials. The deal could be worth up to almost $1 billion if the clinical trials yield positive results.
In October 2012 I was diagnosed with prostate cancer. I am now cancer free. Here is my story, a detailed one, with test results.I have been taking PSA tests every couple years since 2007. It's a routine blood test recommended for men as they get older.PSA stands for Prostate Specific Antigen. Elevated readings may indicate evidence of prostate cancer. Any reading under 3.0 is normal but some doctors may say 4.0 and others 2.5. It's not an exact science to be sure.